The characterisation of a rare immune cell has revealed its role in autoimmune diseases and long-term immunity in a recent study.
The cells, know as T Follicular helper cells, represent less than half a percent of the body’s immune cells. They have the ability to “remember” infections, so they’re well equipped to respond quickly to future attacks.
They also have a strong presence in the occurrence of chronic inflammatory disease, suggesting they should be targeted in any developing treatments.
The T Follicular cells and their involvement in antibody production could lead to improved vaccinations and new treatments for immune disorders.
Read more at WEHI (Walter and Eliza Hall Institute of Medical Research)